Alemtuzumab : Initiating treatment with ZEPOSIA after alemtuzumab is not recommended because of the characteristics and duration of alemtuzumab immune suppressive effects.
Source: FDA drug label - ozanimod hydrochloride
Brand names: Zeposia 7-Day Starter Pack, Zeposia, Zeposia Starter Kit
2 interactions on record
Alemtuzumab : Initiating treatment with ZEPOSIA after alemtuzumab is not recommended because of the characteristics and duration of alemtuzumab immune suppressive effects.
Source: FDA drug label - ozanimod hydrochloride
Class Ia (e.g., quinidine, procainamide) and Class III (e.g., amiodarone, sotalol) anti-arrhythmic drugs have been associated with cases of Torsades de Pointes in patients with bradycardia.
Source: FDA drug label - ozanimod hydrochloride